Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind study of esomeprazole vs omeprazole in reflux esophagitis
jRCT2080220624Phase 3
- Sponsor
- AstraZeneca
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esomeprazole in erosive esophagitis (EE) (3 arms), sponsored by AstraZeneca.
02
Drugs
esomeprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on jRCT2080220624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220624.